Literature DB >> 17588240

Midbrain transcranial sonography in Korean patients with Parkinson's disease.

Ji Youn Kim1, Seong Tae Kim, Seong Hee Jeon, Won Yong Lee.   

Abstract

Transcranial sonography (TCS) is potentially useful for the diagnosis of Parkinson's disease (PD). However, studies on TCS have so far been restricted to European populations. To investigate the efficacy of TCS in Korean PD patients and its correlation with the clinical features, we carried out midbrain TCS in 43 PD patients and 35 normal controls and evaluated the area of the substantia nigra (SN) hyperechogenicity and its ratio to the area of the whole midbrain. In 16 subjects (21%), TCS was unsuccessful due to insufficient acoustic temporal bone windows. The mean area of bilateral SN hyperechogenicity and its ratio to the midbrain area were greater in the PD patients than that in the controls (P < 0.01). In the PD patients, the area of SN hyperechogenicity and its ratio to the individual midbrain area were moderately correlated with the PD duration (r = 0.526 and 0.536, P = 0.01, respectively) but not with the age, UPDRS motor scores or H-Y stage. There was no difference in the SN hyperechogenicity between the tremor-dominant, akinetic-rigid, and mixed-type PD patients. In conclusion, midbrain TCS is an effective diagnostic tool for detecting PD in the Korean population. However, it does not reflect the severity or phenotypes of parkinsonism. 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2007        PMID: 17588240     DOI: 10.1002/mds.21628

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Transcranial sonography on Parkinson's disease and essential tremor in a Chinese population.

Authors:  Wei-Feng Luo; Ying-Chun Zhang; Yu-Jing Sheng; Jun-Chu Fang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2011-12-11       Impact factor: 3.307

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

Review 3.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 4.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

Review 5.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

6.  Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control.

Authors:  Hee Young Shin; Eun Youn Joo; Seong Tae Kim; Hun-Jong Dhong; Jin Whan Cho
Journal:  Neurol Sci       Date:  2012-07-28       Impact factor: 3.307

Review 7.  Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review.

Authors:  Annemarie M M Vlaar; Angela Bouwmans; Werner H Mess; Selma C Tromp; Wim E J Weber
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

8.  Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.

Authors:  Gabrielle Todd; Carolyn Noyes; Stanley C Flavel; Chris B Della Vedova; Peter Spyropoulos; Barry Chatterton; Daniela Berg; Jason M White
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies.

Authors:  Sheng-xin Huang; Fei-xiang Wu; Min Luo; Liang Ma; Ke-feng Gao; Jian Li; Wen-juan Wu; Shan Huang; Qi Yang; Ke Liu; Yin-nong Zhao; Le-qun Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

10.  Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.

Authors:  Angela E P Bouwmans; Annemarie M M Vlaar; Werner H Mess; Alfons Kessels; Wim E J Weber
Journal:  BMJ Open       Date:  2013-04-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.